Management of Pediatric Pseudotumor Cerebri Syndrome

Valeria Dipasquale, Gabriella Di Rosa, Salvatore Savasta, Ornella Merlo, Daniela Concolino, Teresa Arrigo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Pseudotumor cerebri syndrome (PTCS) is a clinical condition characterized by signs and symptoms of elevated intracranial pressure without any radiographic evidence of a mass lesion in the brain, and no abnormalities of the brain parenchyma and cerebrospinal fluid (CSF) composition. Children with PTCS typically present with various combinations of headache, diplopia, and pulsatile tinnitus. Although this syndrome has long been considered a benign condition, it may lead to permanent visual impairment if not promptly and correctly treated. Complete remission of PTCS is associated with a decrease in intracranial pressure, the disappearance of clinical symptoms, and the reversion of papilledema at the funduscopic examination. PTCS has been associated with several comorbidities, but its exact pathophysiology has yet to be fully elucidated. Because the origin of PTCS remains unclear, an etiologically targeted treatment has not yet been identified. Current medical treatments include diuretics (e.g., acetazolamide, furosemide) able to reduce CSF production and pressure, and CSF diversion procedures in the most severe cases. Future elucidation of the pathophysiologic mechanism(s) underlying impaired CSF dynamics in PTCS should help control more finely the CSF formation by choroid plexus with novel drugs having fewer side effects than the commonly used diuretics (e.g., acetazolamide). In this review, we briefly summarize the current therapeutic options in pediatric PTCS.

Original languageEnglish
Pages (from-to)58-61
Number of pages4
JournalJournal of Pediatric Neurology
Volume13
Issue number1
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Pseudotumor Cerebri
Pediatrics
Cerebrospinal Fluid
Acetazolamide
Diuretics
Cerebrospinal Fluid Pressure
Papilledema
Choroid Plexus
Intracranial Hypertension
Diplopia
Tinnitus
Vision Disorders
Furosemide
Intracranial Pressure
Brain
Hydrodynamics
Signs and Symptoms
Headache
Comorbidity
Therapeutics

Keywords

  • children
  • idiopathic intracranial hypertension
  • management
  • pseudotumor cerebri

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Dipasquale, V., Di Rosa, G., Savasta, S., Merlo, O., Concolino, D., & Arrigo, T. (2015). Management of Pediatric Pseudotumor Cerebri Syndrome. Journal of Pediatric Neurology, 13(1), 58-61. https://doi.org/10.1055/s-0035-1555157

Management of Pediatric Pseudotumor Cerebri Syndrome. / Dipasquale, Valeria; Di Rosa, Gabriella; Savasta, Salvatore; Merlo, Ornella; Concolino, Daniela; Arrigo, Teresa.

In: Journal of Pediatric Neurology, Vol. 13, No. 1, 01.03.2015, p. 58-61.

Research output: Contribution to journalArticle

Dipasquale, V, Di Rosa, G, Savasta, S, Merlo, O, Concolino, D & Arrigo, T 2015, 'Management of Pediatric Pseudotumor Cerebri Syndrome', Journal of Pediatric Neurology, vol. 13, no. 1, pp. 58-61. https://doi.org/10.1055/s-0035-1555157
Dipasquale, Valeria ; Di Rosa, Gabriella ; Savasta, Salvatore ; Merlo, Ornella ; Concolino, Daniela ; Arrigo, Teresa. / Management of Pediatric Pseudotumor Cerebri Syndrome. In: Journal of Pediatric Neurology. 2015 ; Vol. 13, No. 1. pp. 58-61.
@article{219f603a7bb047698d772820053982f7,
title = "Management of Pediatric Pseudotumor Cerebri Syndrome",
abstract = "Pseudotumor cerebri syndrome (PTCS) is a clinical condition characterized by signs and symptoms of elevated intracranial pressure without any radiographic evidence of a mass lesion in the brain, and no abnormalities of the brain parenchyma and cerebrospinal fluid (CSF) composition. Children with PTCS typically present with various combinations of headache, diplopia, and pulsatile tinnitus. Although this syndrome has long been considered a benign condition, it may lead to permanent visual impairment if not promptly and correctly treated. Complete remission of PTCS is associated with a decrease in intracranial pressure, the disappearance of clinical symptoms, and the reversion of papilledema at the funduscopic examination. PTCS has been associated with several comorbidities, but its exact pathophysiology has yet to be fully elucidated. Because the origin of PTCS remains unclear, an etiologically targeted treatment has not yet been identified. Current medical treatments include diuretics (e.g., acetazolamide, furosemide) able to reduce CSF production and pressure, and CSF diversion procedures in the most severe cases. Future elucidation of the pathophysiologic mechanism(s) underlying impaired CSF dynamics in PTCS should help control more finely the CSF formation by choroid plexus with novel drugs having fewer side effects than the commonly used diuretics (e.g., acetazolamide). In this review, we briefly summarize the current therapeutic options in pediatric PTCS.",
keywords = "children, idiopathic intracranial hypertension, management, pseudotumor cerebri",
author = "Valeria Dipasquale and {Di Rosa}, Gabriella and Salvatore Savasta and Ornella Merlo and Daniela Concolino and Teresa Arrigo",
year = "2015",
month = "3",
day = "1",
doi = "10.1055/s-0035-1555157",
language = "English",
volume = "13",
pages = "58--61",
journal = "Journal of Pediatric Neuroradiology",
issn = "1304-2580",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Management of Pediatric Pseudotumor Cerebri Syndrome

AU - Dipasquale, Valeria

AU - Di Rosa, Gabriella

AU - Savasta, Salvatore

AU - Merlo, Ornella

AU - Concolino, Daniela

AU - Arrigo, Teresa

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Pseudotumor cerebri syndrome (PTCS) is a clinical condition characterized by signs and symptoms of elevated intracranial pressure without any radiographic evidence of a mass lesion in the brain, and no abnormalities of the brain parenchyma and cerebrospinal fluid (CSF) composition. Children with PTCS typically present with various combinations of headache, diplopia, and pulsatile tinnitus. Although this syndrome has long been considered a benign condition, it may lead to permanent visual impairment if not promptly and correctly treated. Complete remission of PTCS is associated with a decrease in intracranial pressure, the disappearance of clinical symptoms, and the reversion of papilledema at the funduscopic examination. PTCS has been associated with several comorbidities, but its exact pathophysiology has yet to be fully elucidated. Because the origin of PTCS remains unclear, an etiologically targeted treatment has not yet been identified. Current medical treatments include diuretics (e.g., acetazolamide, furosemide) able to reduce CSF production and pressure, and CSF diversion procedures in the most severe cases. Future elucidation of the pathophysiologic mechanism(s) underlying impaired CSF dynamics in PTCS should help control more finely the CSF formation by choroid plexus with novel drugs having fewer side effects than the commonly used diuretics (e.g., acetazolamide). In this review, we briefly summarize the current therapeutic options in pediatric PTCS.

AB - Pseudotumor cerebri syndrome (PTCS) is a clinical condition characterized by signs and symptoms of elevated intracranial pressure without any radiographic evidence of a mass lesion in the brain, and no abnormalities of the brain parenchyma and cerebrospinal fluid (CSF) composition. Children with PTCS typically present with various combinations of headache, diplopia, and pulsatile tinnitus. Although this syndrome has long been considered a benign condition, it may lead to permanent visual impairment if not promptly and correctly treated. Complete remission of PTCS is associated with a decrease in intracranial pressure, the disappearance of clinical symptoms, and the reversion of papilledema at the funduscopic examination. PTCS has been associated with several comorbidities, but its exact pathophysiology has yet to be fully elucidated. Because the origin of PTCS remains unclear, an etiologically targeted treatment has not yet been identified. Current medical treatments include diuretics (e.g., acetazolamide, furosemide) able to reduce CSF production and pressure, and CSF diversion procedures in the most severe cases. Future elucidation of the pathophysiologic mechanism(s) underlying impaired CSF dynamics in PTCS should help control more finely the CSF formation by choroid plexus with novel drugs having fewer side effects than the commonly used diuretics (e.g., acetazolamide). In this review, we briefly summarize the current therapeutic options in pediatric PTCS.

KW - children

KW - idiopathic intracranial hypertension

KW - management

KW - pseudotumor cerebri

UR - http://www.scopus.com/inward/record.url?scp=84950992936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950992936&partnerID=8YFLogxK

U2 - 10.1055/s-0035-1555157

DO - 10.1055/s-0035-1555157

M3 - Article

VL - 13

SP - 58

EP - 61

JO - Journal of Pediatric Neuroradiology

JF - Journal of Pediatric Neuroradiology

SN - 1304-2580

IS - 1

ER -